Stocksigma LogoStocksigma Logo

Nath Bio-Genes Reports H1FY27 Financial and Operational Results

For H1FY27, Nath Bio-Genes reported revenue of ₹3,601 Mn, up 13% YoY from ₹3,199 Mn, while gross profit rose 13% YoY to ₹1,922 Mn with margins flat at 53%

Nath Bio-Genes Reports H1FY27 Financial and Operational Results

Nath Bio-Genes (India) Ltd · Investor Presentation · 16 Nov 2026, 3:35 pm

Nath Bio-Genes Reports H1FY27 Financial and Operational Results For H1FY27, Nath Bio-Genes reported revenue of ₹3,601 Mn, up 13% YoY from ₹3,199 Mn, while gross profit rose 13% YoY to ₹1,922 Mn with margins flat at 53%. EBITDA fell 11% YoY to ₹410 Mn as margins compressed from 14% to 11%. PAT declined 18% YoY to ₹349 Mn due to a 50% increase in finance costs to ₹93 Mn. In Q2FY27, revenue dropped 6% YoY to ₹373 Mn, with PAT down 46% YoY to ₹23 Mn. Paddy (37%), cotton (26%), and bajra (13%) led H1 sales.

Original exchange filing (PDF)

More announcements from Nath Bio-Genes (India) Ltd

All Nath Bio-Genes (India) Ltd announcements